Research

Solazyme’s unique technologies can rapidly generate novel biological catalysts with desired commercial properties. This is accomplished by combining the power of bioproduction with cutting edge genetic engineering methods and microbial genomics to develop high value products for the energy, pharmaceutical, chemical and nutraceutical markets.

Solazyme’s strategy is to target select multi-billion dollar markets where it can help its commercialization partners deliver high margin products.
Please visit methods for more information on Solazyme’s technology.






